Navigation Links
Nomad Bioscience Announces Broad License Agreement
Date:9/29/2008

MUNICH, Germany, Sept. 29 /PRNewswire/ -- Nomad Bioscience GmbH announces that it entered into a broad licensing agreement with Bayer Innovation GmbH and Icon Genetics group. It provides Nomad access to Icon's proprietary technology platforms, including its transient expression technology magnICON(R), for manufacturing biomaterials and selected biosimilar pharmaceutical proteins in green plants. The agreement provides Nomad with a strategically needed freedom to operate in its core business areas. The financial terms of the agreement are not disclosed.

"Icon Genetics' proprietary gene transfer systems provide a broad solution to the upstream part of manufacturing, and combined with Nomad downstream technologies, they should result in a superior fully integrated process for most of our intended product candidates," said Dr. Yuri Gleba, the founder of Nomad Bioscience. Prof. Dr. Gleba is also co-inventor of Icon's technologies as well as co-founder and managing director of Icon Genetics.

"Icon has developed new generation production platforms that are by far more effective than those commercialized today. Since our own strategic focus is on proprietary biopharmaceuticals, we were looking for a partner who could best apply our proprietary expression methods to other new classes of products," said Dr. Detlef Wollweber, Managing Director of Bayer Innovation.

About Nomad Bioscience:

Nomad Bioscience, headquartered in Munich, is a private start-up biotechnology company developing a series of high value materials such as nanopatterned materials, protein scaffolds, proteins and enzymes for important markets including biosimilar biopharmaceuticals, electric batteries and biofuels.


'/>"/>
SOURCE Nomad Bioscience GmbH
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. LI-COR Biosciences Offers $1.75 Million in Matching Funds for Undergraduate Genomics Education
2. Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
3. Tethys Bioscience Announces Acquisition of Lipomics Technologies
4. Ardea Biosciences to Present at the UBS Global Life Sciences Conference and the Third Annual JMP Securities Healthcare Focus Conference
5. Sangamo BioSciences to Present at the UBS Global Life Sciences Conference
6. Industry Pioneer Joins Profectus BioSciences to Support Innovation in Therapeutic and Preventative Vaccines
7. Ardea Biosciences to Present Data on Gout and Inflammation Programs at the 2008 ACR/ARHP Annual Scientific Meeting
8. Pressure BioSciences, Inc. Announces Research Agreement With the US Army Medical Research Institute of Infectious Diseases (USAMRIID)
9. Ardea Biosciences to Present Data on Lead MEK inhibitor, RDEA119, at EORTC-NCI-AACR Symposium
10. Protect Marylands Bioscience Industry
11. Start-Up and Emerging Biotech Companies Will Tell Their Stories at Biosciences Showcase Planned for MichBio Expo
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
(Date:6/23/2016)... A person commits a crime, and the detective ... the criminal down. An outbreak of foodborne illness ... (FDA) uses DNA evidence to track down the bacteria that ... It,s not. The FDA has increasingly used a complex, cutting-edge ... illnesses. Put as simply as possible, whole genome sequencing is ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is pleased ... received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval of ... Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods perform ...
(Date:6/23/2016)... 23, 2016  The Biodesign Challenge (BDC), a university ... to harness living systems and biotechnology, announced its winning ... New York City . ... showcased projects at MoMA,s Celeste Bartos Theater during the ... MoMA,s senior curator of architecture and design, and ...
Breaking Biology Technology:
(Date:4/28/2016)... , April 28, 2016 First quarter ... (139.9), up 966% compared with the first quarter of 2015 ... totaled SEK 589.1 M (loss: 18.8) and the operating margin was ... (loss: 0.32) Cash flow from operations was SEK 249.9 ... 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. The ...
(Date:4/15/2016)... , April 15, 2016 ... the,  "Global Gait Biometrics Market 2016-2020,"  report to ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait biometrics ... of 13.98% during the period 2016-2020. ... angles, which can be used to compute factors ...
(Date:3/29/2016)... LegacyXChange, Inc. (OTC: LEGX ... Protect are pleased to announce our successful effort to ... of writing instruments, ensuring athletes signatures against counterfeiting and ... athletes on LegacyXChange will be assured of ongoing proof ... Bill Bollander , CEO states, "By inserting ...
Breaking Biology News(10 mins):